Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment
Carcinogenesis · 12.11.2026
DOI: 10.1093/carcin/bgag085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 12.11.2026. Verfasst von Hiromi Sato und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Akita University School of Medicine, Akita, Akita 010-8543, Japan.
Abstract (Originalsprache)
Growing epidemiological evidence indicates that dietary fats and obesity are linked to prostate cancer (PCa) progression. This study examines the impact of a lard-based diet (LD) on PCa progression through gut microbiota alterations and immune modulation. Using a prostate-specific Pten knockout mouse model, LD increased the relative abundance of the phylum Proteobacteria, which correlated with higher serum lipopolysaccharide (LPS) levels, weight gain, activation of TGF-β signaling, and accelerated PCa growth. Moreover, LD promoted Foxp3+ T cell infiltration within tumors, enhancing the immunosuppressive tumor microenvironment and driving cancer progression. Antibiotic treatment reduced both Foxp3+ T cell infiltration and serum LPS levels, highlighting the role of gut microbiota in PCa progression. Moreover, inhibiting LPS signaling suppressed high-fat diet-induced Foxp3+ T cell infiltration. In clinical samples, obesity was associated with increased FOXP3+ T cell infiltration in the prostate, while an abundance of gut class ε-Proteobacteria correlated with obesogenic phenotypes and advanced PCa features. These findings suggest that LD-induced gut microbiota changes and immune modulation contribute to PCa progression via systemic inflammation and intratumoral TGF-β signaling, presenting a potential preventive and therapeutic target for PCa.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Akita University School of Medicine, Akita, Akita 010-8543, Japan.
- Department of Organ Anatomy and Nanomedicine, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan.
- Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.
- Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan.
- Department of Occupational therapy, Akita University Graduate School of Health Science, Akita, Akita 010-8543, Japan.
- Department of Urology, Toyonaka Municipal Hospital, Toyonaka, Osaka, 560-8565, Japan.
ORCID-Profile: Hiromi Sato, Shintaro Narita, Shuhei Okada, Huang Mingguo, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Kazuyuki Numakura, Mitsuru Saito, Naoshi Dohmae, Makoto Matsushita, Kazutoshi Fujita, Norio Nonomura, Tomonori Habuchi
Zitieren
APA
Sato, H., Narita, S., Takahashi, Y., Okada, S., Ishida, M., Mingguo, H., Sekine, Y., Kobayashi, M., Kashima, S., Yamamoto, R., Numakura, K., Saito, M., Dohmae, N., Yoshioka, T., Matsushita, M., Fujita, K., Nonomura, N., & Habuchi, T. (2026). Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment. Carcinogenesis. https://doi.org/10.1093/carcin/bgag085
Vancouver
Sato H, Narita S, Takahashi Y, Okada S, Ishida M, Mingguo H, et al. Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment. Carcinogenesis. 2026. doi:10.1093/carcin/bgag085
BibTeX
@article{Sato2026,
author = {Sato, Hiromi and Narita, Shintaro and Takahashi, Yoshiko and Okada, Shuhei and Ishida, Masanori and Mingguo, Huang and Sekine, Yuya and Kobayashi, Mizuki and Kashima, Soki and Yamamoto, Ryohei and Numakura, Kazuyuki and Saito, Mitsuru and Dohmae, Naoshi and Yoshioka, Toshiaki and Matsushita, Makoto and Fujita, Kazutoshi and Nonomura, Norio and Habuchi, Tomonori},
title = {Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment},
journal = {Carcinogenesis},
year = {2026},
doi = {10.1093/carcin/bgag085}
}
EUVIMED